ZIVO Bioscience Past Earnings Performance

Past criteria checks 0/6

ZIVO Bioscience has been growing earnings at an average annual rate of 0.8%, while the Personal Products industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 53.7% per year.

Key information

0.8%

Earnings growth rate

33.0%

EPS growth rate

Personal Products Industry Growth20.9%
Revenue growth rate53.7%
Return on equityn/a
Net Margin-17,327.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

ZIVO Bioscience: Building An IP Portfolio For Algal Biomass Derived Ingredients

Nov 25

Revenue & Expenses Breakdown

How ZIVO Bioscience makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:ZIVO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-14103
30 Jun 240-13103
31 Mar 240-751
31 Dec 230-861
30 Sep 230-962
30 Jun 230-962
31 Mar 230-972
31 Dec 220-962
30 Sep 220-972
30 Jun 220-972
31 Mar 220-972
31 Dec 210-972
30 Sep 210-752
30 Jun 210-963
31 Mar 210-953
31 Dec 200-954
30 Sep 200-1174
30 Jun 200-1063
31 Mar 200-1164
31 Dec 190-1262
30 Sep 190-1042
30 Jun 190-1342
31 Mar 190-1432
31 Dec 180-1533
30 Sep 180-1543
30 Jun 180-1443
31 Mar 180-1243
31 Dec 170-1042
30 Sep 170-732
30 Jun 170-621
31 Mar 170-731
31 Dec 160-631
30 Sep 160-631
30 Jun 160-631
31 Mar 160-621
31 Dec 150-621
30 Sep 150-421
30 Jun 150-622
31 Mar 150-522
31 Dec 140122
30 Sep 140022
30 Jun 140-121
31 Mar 140-521

Quality Earnings: ZIVO is currently unprofitable.

Growing Profit Margin: ZIVO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ZIVO is unprofitable, but has reduced losses over the past 5 years at a rate of 0.8% per year.

Accelerating Growth: Unable to compare ZIVO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZIVO is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-5.2%).


Return on Equity

High ROE: ZIVO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies